Sep 6, 2016 Vedanta Biosciences Granted Third U.S. Patent Covering Methods of Treating Infectious and Allergic Diseases with Bacterial Consortia
Aug 23, 2016 Vedanta Biosciences Granted Second U.S. Patent Covering Methods of Treating Autoimmune Disease with Therapeutics Based on Bacterial Consortia
Aug 16, 2016 Vedanta Biosciences Granted U.S. Patent Broadly Covering Pharmaceutical Compositions for Microbiome Therapeutics Based on Bacterial Consortia
Aug 11, 2016 Vedanta Biosciences Announces Collaboration with the NYU Langone Medical Center to Develop Microbiome-Derived Immunotherapies for Cancer
Mar 30, 2016 Vedanta Biosciences Announces License Agreement with RIKEN and other Japanese Institutions for New Immune Boosting Microbiome Technology
Oct 13, 2015 Vedanta Biosciences Expands Team with Additions of Head of Preclinical Development and Head of Intellectual Property
Jul 10, 2013 Pioneering Study Describes Rationally Designed Drug Candidate Derived From the Human Microbiota
